Airbus's production delays create a rare window for competitors to swoop in and capture market share. Airlines can't wait - they need aircraft now.
When one giant stumbles, the entire aerospace ecosystem shifts. Suppliers, manufacturers and service providers all stand to benefit from this disruption.
These companies represent the cream of aerospace - established players with proven track records who can step up when reliability matters most.
This basket's total market capitalisation is 723,907.49649 and is dominated by large-cap constituents, which tends to offer a relatively stable, core-market profile.
BA: $156.11B
SPR: $4.41B
HWM: $78.91B
Airbus's production delays from fuselage defects create a rare opportunity for market share shifts in the tightly controlled commercial aircraft industry. When one major manufacturer stumbles, airlines still need planes, creating demand for competitors like Boeing and aerospace suppliers.
This group includes Boeing as the primary beneficiary, plus key aerospace suppliers and defense contractors. These companies could see increased orders, higher production rates, and improved investor confidence as airlines seek alternatives to Airbus aircraft.
Each stock was selected based on its potential to benefit from Airbus's troubles - whether through direct competition, supplying critical components to rivals, or providing services to airlines extending their existing fleets whilst avoiding Airbus deliveries.
Airbus has cut its delivery targets after discovering a significant fuselage flaw in its A320 aircraft, causing production delays and requiring widespread inspections. This situation could create a significant opening for its main competitor, Boeing, and other aerospace manufacturers to capture market share from airlines seeking to avoid delivery uncertainties.
Published on December 3
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
HOWMET AEROSPACE INC
HWM
Current Price
$212.47
This company supplies critical engineered components like engine parts and fasteners, and would likely see increased demand from any production ramp-u...
This company supplies critical engineered components like engine parts and fasteners, and would likely see increased demand from any production ramp-up by Airbus's competitors.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
On average, analysts expect assets in this group to grow 10.2% over the next year.
15 of 16 assets in this group are rated Buy by professional analysts.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+10.20%
Get the full story on this Basket. Read our detailed article on its risks and potential.
Read Full InsightTrade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.